In the last few years, strong experimental and clinical evidence has been obtained that supports the idea that the CXCR3 pathway is involved in the development of autoimmune diseases, especially by creating local amplification loops of inflammation in target organs, thereby worsening the clinical manifestations (Lacotte et al., 2009). This evidence concerns the gene CXCR3 and autoimmune disease.